Lannett To Participate At Two Investment Conferences In December
Get Alerts LCI Hot Sheet
Join SI Premium – FREE
PHILADELPHIA, Dec. 7, 2016 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 at 9:20 a.m. (ET) at the InterContinental Barclay hotel in New York City.
In addition, the company will host one-on-one meetings with institutional investors participating at the Guggenheim Securities 4th Annual Boston Healthcare Conference taking place on December 13, 2016 at the InterContinental Boston hotel.
A webcast of the BMO presentation will be available at www.lannett.com. Listeners are encouraged to visit the web site at least 10 minutes prior to the start of the presentation to register, download and install any necessary software. The presentation will be archived and accessible on the web site for at least 90 days.
About Lannett Company, Inc.:Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com.
|
Contact: |
Robert Jaffe |
|
Robert Jaffe Co., LLC | |
|
(424) 288-4098 |
Logo - http://photos.prnewswire.com/prnh/20150417/199461LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lannett-to-participate-at-two-investment-conferences-in-december-300373976.html
SOURCE Lannett Company, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brown-Forman Board Issues Statement
- RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
- After Arrest Controversy, "Empire State Building Couple" Angela Nikolau and Ivan Beerkus to Address Recent Incident on Gosh Live
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BMO Capital, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share